UNSPSC 51102830: Cetylpyridinium/chloroxylenol/triacetin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102830 Cetylpyridinium/chloroxylenol/triacetin is a Commodity code showing minimal recent state and local procurement activity directly aligned with this specific chemical formulation. The three most recent opportunities posted under this code—spanning Florida, Texas, and Minnesota—involve naloxone procurement, pharmacy benefit program vendor capabilities, and generic pharmaceutical supply, none of which target the antimicrobial or oral-care chemical compounds the code nominally describes. The City of Tampa's medical and first aid supplies bid for the Fire Department Rescue Division and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic pharmaceuticals represent the closest fit, as both include medical-grade consumables and over-the-counter products distributed through state and local health and emergency-response channels, but neither explicitly specifies cetylpyridinium or related antimicrobial agents. Issuing bodies on recent opportunities include county health departments (Seminole County, Florida), state agencies (Texas Health and Human Services Commission, Minnesota Department of Administration), and municipal purchasing offices (City of Tampa), typically sourcing through competitive bidding or cooperative purchasing vehicles rather than direct manufacturer relationships.

Geographic activity clusters in Florida, Texas, and Minnesota based on the recent-opportunities block, with the MMCAP cooperative vehicle extending reach across participating state and local government facilities including Oregon. The Seminole County naloxone IFB (due July 26, 2023, notice IFB60459723LAS) sought 1,900 units annually with quarterly deliveries to the Sanford community health facility; the City of Tampa's medical supplies bid (26P00145, due March 13, 2026) estimated $700,000 and included a 5 percent small local business enterprise (SLBE) discount; and the MMCAP RFP (S1070000015802, due March 26, 2026) sought generic multi-source pharmaceuticals through authorized wholesalers with a July 1, 2026 contract effective date. The Texas HHS Request for Information (HHS0017013) on direct-to-manufacturer pharmacy programs and the MMCAP cooperative structure suggest growing state-level interest in manufacturer-direct supply models, though neither explicitly targets this code's nominal chemical formulation. Substantive recent procurement under UNSPSC 51102830 itself remains absent from the available opportunities.